{"transactions":[{"id":2377312,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, TBIL"}}],"security":"Ordinary Shares","published_at":"2022-02-23T23:18:44.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":8369,"price":9.61,"value":80426.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":110319,"source":{"system":"sec-edgar","filing":"0001415889-22-001693","document":"form4-02232022_030232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922001693/form4-02232022_030232.xml","form_type":"4"}},{"id":2497116,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, TBIL"}}],"security":"Ordinary Shares","published_at":"2021-11-24T01:26:24.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":3169,"price":8.36,"value":26492.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":118688,"source":{"system":"sec-edgar","filing":"0001415889-21-005472","document":"form4-11232021_051113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588921005472/form4-11232021_051113.xml","form_type":"4"}},{"id":2591889,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2021-08-24T22:50:26.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":3169,"price":14.05,"value":44524.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":121857,"source":{"system":"sec-edgar","filing":"0001179110-21-008390","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021008390/edgar.xml","form_type":"4"}},{"id":2698227,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2021-05-24T22:07:41.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":3169,"price":17.8,"value":56408.2,"ownership":{"direct":true},"balance_after":125026,"source":{"system":"sec-edgar","filing":"0001179110-21-005838","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021005838/edgar.xml","form_type":"4"}},{"id":2838135,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2021-02-23T23:01:01.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":10092,"price":18.79,"value":189628.68,"ownership":{"direct":true},"balance_after":128195,"source":{"system":"sec-edgar","filing":"0001179110-21-002152","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021002152/edgar.xml","form_type":"4"}},{"id":2868533,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2021-02-10T22:39:38.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":138287,"source":{"system":"sec-edgar","filing":"0001179110-21-001535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021001535/edgar.xml","form_type":"4"}},{"id":2967449,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2020-11-24T23:13:00.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":2292,"price":17.21,"value":39445.32,"ownership":{"direct":true},"balance_after":98287,"source":{"system":"sec-edgar","filing":"0001179110-20-011363","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020011363/edgar.xml","form_type":"4"}},{"id":3048387,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2020-08-24T22:19:24.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":2292,"price":18.22,"value":41760.24,"ownership":{"direct":true},"balance_after":100579,"source":{"system":"sec-edgar","filing":"0001179110-20-009259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020009259/edgar.xml","form_type":"4"}},{"id":3136542,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2020-05-22T22:05:32.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":2292,"price":26.67,"value":61127.64,"ownership":{"direct":true},"balance_after":102871,"source":{"system":"sec-edgar","filing":"0001179110-20-006521","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020006521/edgar.xml","form_type":"4"}},{"id":3252008,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2020-02-25T00:05:26.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":5948,"price":25.9,"value":154053.2,"ownership":{"direct":true},"balance_after":105163,"source":{"system":"sec-edgar","filing":"0001179110-20-002141","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020002141/edgar.xml","form_type":"4"}},{"id":3288125,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2020-02-05T23:55:25.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111111,"source":{"system":"sec-edgar","filing":"0001179110-20-001196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020001196/edgar.xml","form_type":"4"}},{"id":3360795,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2019-11-22T23:18:37.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":1073,"price":17.6,"value":18884.8,"ownership":{"direct":true},"balance_after":71111,"source":{"system":"sec-edgar","filing":"0001179110-19-012011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019012011/edgar.xml","form_type":"4"}},{"id":3430788,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2019-08-22T21:58:53.000Z","date":"2019-08-20","kind":"tax_withholding","acquired":false,"shares":1073,"price":21.51,"value":23080.23,"ownership":{"direct":true},"balance_after":72184,"source":{"system":"sec-edgar","filing":"0001179110-19-009783","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019009783/edgar.xml","form_type":"4"}},{"id":3514732,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2019-05-22T22:03:39.000Z","date":"2019-05-20","kind":"tax_withholding","acquired":false,"shares":1073,"price":19.84,"value":21288.32,"ownership":{"direct":true},"balance_after":73257,"source":{"system":"sec-edgar","filing":"0001179110-19-006516","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019006516/edgar.xml","form_type":"4"}},{"id":3638114,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130075,"kind":"person","name":"BRADY ANN","position":1,"cik":"0001767974","reported_name":"BRADY ANN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, TBIL"}}],"security":"Ordinary Shares","published_at":"2019-02-22T23:11:07.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":3023,"price":27,"value":81621.0,"ownership":{"direct":true},"balance_after":74330,"source":{"system":"sec-edgar","filing":"0001179110-19-002406","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019002406/edgar.xml","form_type":"4"}}]}